The ADRB2 signaling pathway has been recognized in previous studies as being able to serve in gastric carcinogenesis and metastasis as a β- adrenergic stress activation and might involve autophagy in this process, along with being shown to act as a prognostically negative biomarker for gastric cancer (31–33). Here, ADRB2 is linked to gastric cancer.